Physician

Amanda L Creel, NP

According to 2025 Medicare claims, Amanda Creel, NP (NPI: 1023546843) practices nurse practitioner in the Watertown-Fort Drum, NY market, with the plurality of this provider's patient population coming from Jefferson, NY. This provider's primary affiliated billing organization is THRIVE WELLNESS AND RECOVERY, INC (NPI: 1659389021; TIN: 16-1012469) and primary practice location at 13601-1337.

Creel's data goes back to 2015 and runs through 2024. For example, in 2020, this provider had 13 traditional Medicare patients, billed 31 HCPCS/CPT codes, and received $1,342 in Medicare payments. 2024 Part D data shows 530 prescription claims across 33 beneficiaries totaling $91,065 in drug costs, led by Caplyta (Lumateperone Tosylate). Open Payments data shows 9 records totaling $188. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $5,095 to $91,065. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.6K$3.1K2018 Medicare payment: $3,128 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,110 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,342 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
20182986$3,128
20191243$2,110
20201331$1,342
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$46K$91K2017 Drug cost: $5,095 (USD; Tot_Drug_Cst)2018 Drug cost: $49,886 (USD; Tot_Drug_Cst)2019 Drug cost: $7,647 (USD; Tot_Drug_Cst)2020 Drug cost: $8,513 (USD; Tot_Drug_Cst)2021 Drug cost: $169 (USD; Tot_Drug_Cst)2023 Drug cost: $40,919 (USD; Tot_Drug_Cst)2024 Drug cost: $91,065 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/R37$5,095
201834447$49,886
201920305$7,647
202023268$8,513
2021N/R13$169
2022N/RN/RN/R
202327293$40,919
202433530$91,065

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

No connected Part B code-level records for 2024.

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
CaplytaLumateperone Tosylate16480$28,577
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl711,635$8,101
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine11330$481
Hydroxyzine HclHydroxyzine Hcl26522$359
LamotrigineLamotrigine391,284$344

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.9$188ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Amanda L. Creel, NP?

Tedicare shows public-source Medicare data for Amanda L. Creel, NP (NPI 1023546843), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amanda L. Creel, NP have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Amanda L. Creel, NP?

Amanda L. Creel, NP is linked to THRIVE WELLNESS AND RECOVERY, INC (billing NPI 1659389021) in the available physician profile data.

Does Amanda L. Creel, NP have Open Payments data?

Amanda L. Creel, NP has 9 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.